drugset / Trial / NCT04176419

Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery

NCT04176419

Phase 3 Terminated 30 enrolled Case Comprehensive Cancer Center
RandomizedParallel-groupTriple-blindSupportive care

Summary

The purpose of this study is to determine how a non-opioid pain control regimen, administered before and during surgery, will affect postoperative pain control and total opioid consumption in head and neck cancer participants undergoing cancer surgery with free flap reconstruction.

Timeline

Start
2020-01-17
Primary completion
2021-06-23
Completion
2021-06-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg Oral
Subject Celecoxib Other / unclassified 200 mg Oral
Subject Gabapentin Small molecule 600 mg Oral
Subject Ketamine Small molecule 0.005 mg/kg Intravenous
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications

No indication recorded.